Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	Hepatology 2012 (546 pages, free PDF) Hepatitis C 2012 (150 pages, free PDF)	Free Medical Books

Head and Neck Cancer

Free Subscription Articles published in J Clin Endocrinol Metab Retrieve available abstracts of 107 articles: HTML format Text format

Single Articles

May 2012
1. FAUSTINO A , Couto JP, Populo H, Rocha AS, et al
   mTOR Pathway Overactivation in BRAF Mutated Papillary Thyroid Carcinoma.
   J Clin Endocrinol Metab. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   April 2012
2. LATROFA F , Ricci D, Montanelli L, Rocchi R, et al
   Lymphocytic Thyroiditis on Histology Correlates with Serum Thyroglobulin Autoantibodies in Patients with Papillary Thyroid Carcinoma: Impact on Detection of Serum Thyroglobulin.
   J Clin Endocrinol Metab. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. GUERRA A , Fugazzola L, Marotta V, Cirillo M, et al
   A High Percentage of BRAFV600E Alleles in Papillary Thyroid Carcinoma Predicts a Poorer Outcome.
   J Clin Endocrinol Metab. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. YU S , Liu Y, Wang J, Guo Z, et al
   Circulating MicroRNA Profiles as Potential Biomarkers for Diagnosis of Papillary Thyroid Carcinoma.
   J Clin Endocrinol Metab. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   March 2012
5. COOK MI , Qureshi YA, Todd CE, Cummins RS, et al
   An Unusual Ectopic Location of a Parathyroid Carcinoma Arising within the Thyroid Gland.
   J Clin Endocrinol Metab. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. PISCAZZI A , Costantino E, Maddalena F, Natalicchio MI, et al
   Activation of the RAS/RAF/ERK Signaling Pathway Contributes to Resistance to Sunitinib in Thyroid Carcinoma Cell Lines.
   J Clin Endocrinol Metab. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. XU L , Morari EC, Wei Q, Sturgis EM, et al
   Functional Variations in the ATM Gene and Susceptibility to Differentiated Thyroid Carcinoma.
   J Clin Endocrinol Metab. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. KUMAR P , Thukuntla S, Eskew J
   Anaplastic Thyroid Carcinoma with Cutaneous Extension.
   J Clin Endocrinol Metab. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. ESPOSITO F , Tornincasa M, Pallante P, Federico A, et al
   Down-Regulation of the miR-25 and miR-30d Contributes to the Development of Anaplastic Thyroid Carcinoma Targeting the Polycomb Protein EZH2.
   J Clin Endocrinol Metab. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   January 2012
10. CHEN G , Xu S, Renko K, Derwahl M, et al
    Metformin Inhibits Growth of Thyroid Carcinoma Cells, Suppresses Self-Renewal of Derived Cancer Stem Cells, and Potentiates the Effect of Chemotherapeutic Agents.
    J Clin Endocrinol Metab. 2012.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. SILYE R , Rieger R, Topakian R, Dunzinger A, et al
    Cushing Syndrome due to Ectopic Adrenocorticotropin Secretion by Oncocytic Thyroid Nodule.
    J Clin Endocrinol Metab. 2012;97:39-40.
    PubMed     Text format     Related articles   
    
    
    
    December 2011
12. GUERRA A , Sapio MR, Marotta V, Campanile E, et al
    The Primary Occurrence of BRAFV600E Is a Rare Clonal Event in Papillary Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. LODISH M , Dagalakis U, Chen CC, Sinaii N, et al
    111In-Octreotide Scintigraphy for Identification of Metastatic Medullary Thyroid Carcinoma in Children and Adolescents.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. ELISEI R , Romei C, Renzini G, Bottici V, et al
    The Timing of Total Thyroidectomy in RET Gene Mutation Carriers Could Be Personalized and Safely Planned on the Basis of Serum Calcitonin: 18 Years Experience at One Single Center.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2011
15. LIU R , Liu D, Xing M
    The Akt Inhibitor MK2206 Synergizes, but Perifosine Antagonizes, the BRAFV600E Inhibitor PLX4032 and the MEK1/2 Inhibitor AZD6244 in the Inhibition of Thyroid Cancer Cells.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. CHIAPPETTA G , Basile A, Arra C, Califano D, et al
    BAG3 Down-Modulation Reduces Anaplastic Thyroid Tumor Growth by Enhancing Proteasome-Mediated Degradation of BRAF Protein.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. AHMED M , Uddin S, Hussain AR, Alyan A, et al
    FoxM1 and Its Association with Matrix Metalloproteinases (MMP) Signaling Pathway in Papillary Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
18. GIER B , Butler PC, Lai CK, Kirakossian D, et al
    Glucagon Like Peptide-1 Receptor Expression in the Human Thyroid Gland.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. BURROWS N , Babur M, Resch J, Ridsdale S, et al
    GDC-0941 Inhibits Metastatic Characteristics of Thyroid Carcinomas by Targeting both the Phosphoinositide-3 Kinase (PI3K) and Hypoxia-Inducible Factor-1{alpha} (HIF-1{alpha}) Pathways.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. YIM JH , Kim WB, Kim EY, Kim WG, et al
    Adjuvant Radioactive Therapy after Reoperation for Locoregionally Recurrent Papillary Thyroid Cancer in Patients Who Initially Underwent Total Thyroidectomy and High-Dose Remnant Ablation.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
21. COLAMAIO M , Borbone E, Russo L, Bianco M, et al
    miR-191 Down-Regulation Plays a Role in Thyroid Follicular Tumors through CDK6 Targeting.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. NGEOW J , Mester J, Rybicki LA, Ni Y, et al
    Incidence and Clinical Characteristics of Thyroid Cancer in Prospective Series of Individuals with Cowden and Cowden-Like Syndrome Characterized by Germline PTEN, SDH, or KLLN Alterations.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. HARARI A , Waring A, Fernandez-Ranvier G, Hwang J, et al
    Parathyroid Carcinoma: A 43-Year Outcome and Survival Analysis.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. MITSIADES N , Pazaitou-Panayiotou K, Aronis KN, Moon HS, et al
    Circulating Adiponectin Is Inversely Associated with Risk of Thyroid Cancer: In Vivo and in Vitro Studies.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. SPENCER CA
    Clinical Utility of Thyroglobulin Antibody (TgAb) Measurements for Patients with Differentiated Thyroid Cancers (DTC).
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. JENDRZEJEWSKI J , Tomsic J, Lozanski G, Labanowska J, et al
    Telomere Length and Telomerase Reverse Transcriptase Gene Copy Number in Patients with Papillary Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. HAY ID , Charboneau JW
    The coming of age of ultrasound-guided percutaneous ethanol ablation of selected neck nodal metastases in well-differentiated thyroid carcinoma.
    J Clin Endocrinol Metab. 2011;96:2717-20.
    PubMed     Text format     Related articles   
    
    
    
    
28. WEIDINGER C , Krause K, Mueller K, Klagge A, et al
    FOXO3 is inhibited by oncogenic PI3K/Akt signaling but can be reactivated by the NSAID sulindac sulfide.
    J Clin Endocrinol Metab. 2011;96:E1361-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
29. YASUOKA H , Kodama R, Hirokawa M, Takamura Y, et al
    Neuropilin-2 Expression in Papillary Thyroid Carcinoma: Correlation with VEGF-D Expression, Lymph Node Metastasis, and VEGF-D-Induced Aggressive Cancer Cell Phenotype.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. NIKIFOROV YE , Ohori NP, Hodak SP, Carty SE, et al
    Impact of Mutational Testing on the Diagnosis and Management of Patients with Cytologically Indeterminate Thyroid Nodules: A Prospective Analysis of 1056 FNA Samples.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. LIPPOLIS PV , Tognini S, Materazzi G, Polini A, et al
    Is Elastography Actually Useful in the Presurgical Selection of Thyroid Nodules with Indeterminate Cytology?
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. CAPEZZONE M , Cantara S, Marchisotta S, Busonero G, et al
    Telomere Length in Neoplastic and Nonneoplastic Tissues of Patients with Familial and Sporadic Papillary Thyroid Cancer.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. LI H , Robinson KA, Anton B, Saldanha IJ, et al
    Cost-Effectiveness of a Novel Molecular Test for Cytologically Indeterminate Thyroid Nodules.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. DE LA CHAPELLE A , Jazdzewski K
    MicroRNAs in Thyroid Cancer.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. KLUBO-GWIEZDZINSKA J , Van Nostrand D, Atkins F, Burman K, et al
    Efficacy of Dosimetric Versus Empiric Prescribed Activity of 131I for Therapy of Differentiated Thyroid Cancer.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. NOWICKI TS , Moscatello AL, Shin E, Schantz S, et al
    The Urokinase Plasminogen Activator System in Metastatic Papillary Thyroid Carcinoma: A Potential Therapeutic Target.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
37. VAN NOSTRAND D , Atkins F
    Pediatric differentiated thyroid cancer: can the prescribed activity of I-131 be increased?
    J Clin Endocrinol Metab. 2011;96:2401-3.
    PubMed     Text format     Related articles   
    
    
    
    
38. WEXLER JA
    Approach to the thyroid cancer patient with bone metastases.
    J Clin Endocrinol Metab. 2011;96:2296-307.
    PubMed     Text format     Related articles   
    
    
    
    
39. BRIERLEY JD
    Update on external beam radiation therapy in thyroid cancer.
    J Clin Endocrinol Metab. 2011;96:2289-95.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. NEUMANN HP , Sullivan M, Winter A, Malinoc A, et al
    Germline mutations of the TMEM127 gene in patients with paraganglioma of head and neck and extraadrenal abdominal sites.
    J Clin Endocrinol Metab. 2011;96:E1279-82.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. LEE P , Zhao JT, Swarbrick MM, Gracie G, et al
    High prevalence of brown adipose tissue in adult humans.
    J Clin Endocrinol Metab. 2011;96:2450-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. BENADERET AD , Burton AM, Clifton-Bligh R, Ashraf AP, et al
    Primary hyperparathyroidism with low intact PTH levels in a 14-year-old girl.
    J Clin Endocrinol Metab. 2011;96:2325-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
43. DURANTE C , Filetti S
    Management of Papillary Thyroid Cancer Patients in Absence of Postoperative Radioiodine Remnant Ablation: Tailoring Follow-Up by Neck Sonography.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
44. QIU ZL , Song HJ, Xu YH, Luo QY, et al
    Efficacy and Survival Analysis of 131I Therapy for Bone Metastases from Differentiated Thyroid Cancer.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. KLUBO-GWIEZDZINSKA J , Manes RP, Chia SH, Burman KD, et al
    Ectopic Cervical Thyroid Carcinoma--Review of the Literature with Illustrative Case Series.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. LEONE V , D'Angelo D, Rubio I, de Freitas PM, et al
    MiR-1 Is a Tumor Suppressor in Thyroid Carcinogenesis Targeting CCND2, CXCR4, and SDF-1{alpha}
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. KING KS , Chen CC, Alexopoulos DK, Whatley MA, et al
    Functional Imaging of SDHx-Related Head and Neck Paragangliomas: Comparison of 18F-Fluorodihydroxyphenylalanine, 18F-Fluorodopamine, 18F-Fluoro-2-Deoxy-D-Glucose PET, 123I-Metaiodobenzylguanidine Scintigraphy, and 111In-Pentetreotide Scintigraphy.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. SCHUFF KG
    Management of recurrent/persistent papillary thyroid carcinoma: efficacy of the surgical option.
    J Clin Endocrinol Metab. 2011;96:2038-9.
    PubMed     Text format     Related articles   
    
    
    
    June 2011
49. HOFTIJZER HC , Heemstra KA, Visser TJ, le Cessie S, et al
    The Type 2 Deiodinase ORFa-Gly3Asp Polymorphism (rs12885300) Influences the Set Point of the Hypothalamus-Pituitary-Thyroid Axis in Patients Treated for Differentiated Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. HEILO A , Sigstad E, Fagerlid KH, Haskjold OI, et al
    Efficacy of Ultrasound-Guided Percutaneous Ethanol Injection Treatment in Patients with a Limited Number of Metastatic Cervical Lymph Nodes from Papillary Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. GRUSSENDORF M , Reiners C, Paschke R, Wegscheider K, et al
    Reduction of Thyroid Nodule Volume by Levothyroxine and Iodine Alone and in Combination: A Randomized, Placebo-Controlled Trial.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
52. BRASSARD M , Neraud B, Trabado S, Salenave S, et al
    Endocrine Effects of the Tyrosine Kinase Inhibitor Vandetanib in Patients Treated for Thyroid Cancer.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. MACIEL LM , Gomes PM, Magalhaes PK, Filho FV, et al
    A giant primary hemangioma of the thyroid gland.
    J Clin Endocrinol Metab. 2011;96:1623-4.
    PubMed     Text format     Related articles   
    
    
    
    
54. HOEFIG CS , Kohrle J, Brabant G, Dixit K, et al
    Evidence for extrathyroidal formation of 3-iodothyronamine in humans as provided by a novel monoclonal antibody-based chemiluminescent serum immunoassay.
    J Clin Endocrinol Metab. 2011;96:1864-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
55. VERBURG FA , Biko J, Diessl S, Demidchik Y, et al
    I-131 Activities as High as Safely Administrable (AHASA) for the Treatment of Children and Adolescents with Advanced Differentiated Thyroid Cancer.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. FERRAZ C , Eszlinger M, Paschke R
    Current State and Future Perspective of Molecular Diagnosis of Fine-Needle Aspiration Biopsy of Thyroid Nodules.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. TALA H , Robbins R, Fagin JA, Larson SM, et al
    Five-Year Survival Is Similar in Thyroid Cancer Patients with Distant Metastases Prepared for Radioactive Iodine Therapy with either Thyroid Hormone Withdrawal or Recombinant Human TSH.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. RAPA I , Saggiorato E, Giachino D, Palestini N, et al
    Mammalian Target of Rapamycin Pathway Activation Is Associated to RET Mutation Status in Medullary Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
59. DUFOUR DR
    Thyroglobulin antibodies--failing the test.
    J Clin Endocrinol Metab. 2011;96:1276-8.
    PubMed     Text format     Related articles   
    
    
    
    April 2011
60. FALLAH M , Kharazmi E, Sundquist J, Hemminki K, et al
    Nonendocrine Cancers Associated with Benign and Malignant Parathyroid Tumors.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
61. YIM JH , Kim WB, Kim EY, Kim WG, et al
    The Outcomes of First Reoperation for Locoregionally Recurrent/Persistent Papillary Thyroid Carcinoma in Patients Who Initially Underwent Total Thyroidectomy and Remnant Ablation.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. VITALE M
    Targeted therapy for thyroid cancer: striking the survival signaling.
    J Clin Endocrinol Metab. 2011;96:936-8.
    PubMed     Text format     Related articles   
    
    
    
    
63. COSTA-GUDA J , Marinoni I, Molatore S, Pellegata NS, et al
    Somatic mutation and germline sequence abnormalities in CDKN1B, encoding p27Kip1, in sporadic parathyroid adenomas.
    J Clin Endocrinol Metab. 2011;96:E701-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
64. MALANDRINO P , Latina A, Marescalco S, Spadaro A, et al
    Risk-Adapted Management of Differentiated Thyroid Cancer Assessed by a Sensitive Measurement of Basal Serum Thyroglobulin.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. SAPIO MR , Guerra A, Marotta V, Campanile E, et al
    High Growth Rate of Benign Thyroid Nodules Bearing RET/PTC Rearrangements.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. SALERNO P , Garcia-Rostan G, Piccinin S, Bencivenga TC, et al
    TWIST1 Plays a Pleiotropic Role in Determining the Anaplastic Thyroid Cancer Phenotype.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. BRASSARD M , Borget I, Edet-Sanson A, Giraudet AL, et al
    Long-Term Follow-Up of Patients with Papillary and Follicular Thyroid Cancer: A Prospective Study on 715 Patients.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. DERWAHL M
    Linking stem cells to thyroid cancer.
    J Clin Endocrinol Metab. 2011;96:610-3.
    PubMed     Text format     Related articles   
    
    
    
    
69. STATHATOS N , Gaz R, Ross DS, Daniels GH, et al
    High Radioactive Iodine Uptake Despite a Fully Suppressed TSH in a Patient with Thyroid Cancer.
    J Clin Endocrinol Metab. 2011;96:589.
    PubMed     Text format     Related articles   
    
    
    
    February 2011
70. DU ZX , Yan Y, Zhang HY, Liu BQ, et al
    Proteasome Inhibition Induces a p38 MAPK Pathway-Dependent Antiapoptotic Program via Nrf2 in Thyroid Cancer Cells.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. AHMED SR , Ball DW
    Incidentally Discovered Medullary Thyroid Cancer: Diagnostic Strategies and Treatment.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. MOURA MM , Cavaco BM, Pinto AE, Leite V, et al
    High Prevalence of RAS Mutations in RET-Negative Sporadic Medullary Thyroid Carcinomas.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. SPENCER C , Petrovic I, Fatemi S
    Current Thyroglobulin Autoantibody (TgAb) Assays Often Fail to Detect Interfering TgAb that Can Result in the Reporting of Falsely Low/Undetectable Serum Tg IMA Values for Patients with Differentiated Thyroid Cancer.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. BORBONE E , Troncone G, Ferraro A, Jasencakova Z, et al
    Enhancer of Zeste Homolog 2 Overexpression Has a Role in the Development of Anaplastic Thyroid Carcinomas.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. LIU R , Liu D, Trink E, Bojdani E, et al
    The Akt-Specific Inhibitor MK2206 Selectively Inhibits Thyroid Cancer Cells Harboring Mutations That Can Activate the PI3K/Akt Pathway.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. HONG DS , Cabanillas ME, Wheler J, Naing A, et al
    Inhibition of the Ras/Raf/MEK/ERK and RET Kinase Pathways with the Combination of the Multikinase Inhibitor Sorafenib and the Farnesyltransferase Inhibitor Tipifarnib in Medullary and Differentiated Thyroid Malignancies.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. BENVENGA S
    Emerging Therapies in Sight for the Fight against Dedifferentiated Thyroid Cancer.
    J Clin Endocrinol Metab. 2011;96:347-50.
    PubMed     Text format     Related articles   
    
    
    
    
78. MAZZAFERRI EL
    Approach to the pregnant patient with thyroid cancer.
    J Clin Endocrinol Metab. 2011;96:265-72.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
79. VANSTONE MB , Udelsman RD, Cheng DW, Carpenter TO, et al
    Rapid correction of bone mass after parathyroidectomy in an adolescent with primary hyperparathyroidism.
    J Clin Endocrinol Metab. 2011;96:E347-50.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
80. KIM SK , Hwang TS, Yoo YB, Han HS, et al
    Surgical Results of Thyroid Nodules according to a Management Guideline Based on the BRAFV600E Mutation Status.
    J Clin Endocrinol Metab. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. CERUTTI JM , Oler G, Delcelo R, Gerardt R, et al
    PVALB, a new Hurthle adenoma diagnostic marker identified through gene expression.
    J Clin Endocrinol Metab. 2011;96:E151-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
82. ROHMER V , Vidal-Trecan G, Bourdelot A, Niccoli P, et al
    Prognostic Factors of Disease-Free Survival after Thyroidectomy in 170 Young Patients with a RET Germline Mutation: A Multicenter Study of the Groupe Francais d'Etude des Tumeurs Endocrines.
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. LIN CI , Du J, Shen WT, Whang EE, et al
    Mitogen-Inducible Gene-6 Is a Multifunctional Adaptor Protein with Tumor Suppressor-Like Activity in Papillary Thyroid Cancer.
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. JAZDZEWSKI K , Boguslawska J, Jendrzejewski J, Liyanarachchi S, et al
    Thyroid Hormone Receptor {beta} (THRB) Is a Major Target Gene for MicroRNAs Deregulated in Papillary Thyroid Carcinoma (PTC).
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
85. ANTONELLI A , Bocci G, La Motta C, Ferrari SM, et al
    Novel Pyrazolopyrimidine Derivatives as Tyrosine Kinase Inhibitors with Antitumoral Activity in Vitro and in Vivo in Papillary Dedifferentiated Thyroid Cancer.
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
86. HEGEDUS L
    Can elastography stretch our understanding of thyroid histomorphology?
    J Clin Endocrinol Metab. 2010;95:5213-5.
    PubMed     Text format     Related articles   
    
    
    
    
87. HEGEDUS L , Bonnema SJ
    Approach to management of the patient with primary or secondary intrathoracic goiter.
    J Clin Endocrinol Metab. 2010;95:5155-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. MALAGUARNERA R , Frasca F, Garozzo A, Giani F, et al
    Insulin Receptor Isoforms and Insulin-Like Growth Factor Receptor in Human Follicular Cell Precursors from Papillary Thyroid Cancer and Normal Thyroid.
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
89. ULISSE S , Baldini E, Sorrenti S, Barollo S, et al
    High Expression of the Urokinase Plasminogen Activator and Its Cognate Receptor Associates with Advanced Stages and Reduced Disease-Free Interval in Papillary Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
90. RUMYANTSEV PO , Saenko VA, Ilyin AA, Stepanenko VF, et al
    Radiation Exposure Does Not Significantly Contribute to the Risk of Recurrence of Chernobyl Thyroid Cancer.
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
91. GARDNER CJ , Wieshmann H, Gosney J, Carr HM, et al
    Localization of Metastatic Parathyroid Carcinoma by 18F FDG PET Scanning.
    J Clin Endocrinol Metab. 2010;95:4844-5.
    PubMed     Text format     Related articles   
    
    
    
    October 2010
92. SMITH JR , Marqusee E, Webb S, Nose V, et al
    Thyroid Nodules and Cancer in Children with PTEN Hamartoma Tumor Syndrome.
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
93. VALLE LA , Kloos RT
    The Prevalence of Occult Medullary Thyroid Carcinoma at Autopsy.
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
94. SIRAJ AK , Hussain AR, Al-Rasheed M, Ahmed M, et al
    Demethylation of TMS1 Gene Sensitizes Thyroid Cancer Cells to TRAIL-Induced Apoptosis.
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
95. LEE MH , Lee SE, Kim DW, Ryu MJ, et al
    Mitochondrial Localization and Regulation of BRAFV600E in Thyroid Cancer: A Clinically Used RAF Inhibitor Is Unable to Block the Mitochondrial Activities of BRAFV600E.
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
96. SEBAG F , Vaillant-Lombard J, Berbis J, Griset V, et al
    Shear Wave Elastography: A New Ultrasound Imaging Mode for the Differential Diagnosis of Benign and Malignant Thyroid Nodules.
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. CHAMBON G , Alovisetti C, Idoux-Louche C, Reynaud C, et al
    The Use of Preoperative Routine Measurement of Basal Serum Thyrocalcitonin in Candidates for Thyroidectomy due to Nodular Thyroid Disorders: Results from 2733 Consecutive Patients.
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
98. KLOOS RT
    Thyroid Cancer Recurrence in Patients Clinically Free of Disease with Undetectable or Very Low Serum Thyroglobulin Values.
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
99. CHUDOVA D , Wilde JI, Wang ET, Wang H, et al
    Molecular Classification of Thyroid Nodules Using High-Dimensionality Genomic Data.
    J Clin Endocrinol Metab. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
100. SCHULTE KM , Machens A, Fugazzola L, McGregor A, et al
     The clinical spectrum of multiple endocrine neoplasia type 2a caused by the rare intracellular RET mutation S891A.
     J Clin Endocrinol Metab. 2010;95:E92-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
101. RAGO T , Scutari M, Santini F, Loiacono V, et al
     Real-Time Elastosonography: Useful Tool for Refining the Presurgical Diagnosis in Thyroid Nodules with Indeterminate or Nondiagnostic Cytology.
     J Clin Endocrinol Metab. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     August 2010
102. BASS MB , Sherman SI, Schlumberger MJ, Davis MT, et al
     Biomarkers as Predictors of Response to Treatment with Motesanib in Patients with Progressive Advanced Thyroid Cancer.
     J Clin Endocrinol Metab. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
103. ADAM MA , Untch BR, Danko ME, Stinnett S, et al
     Severe Obesity Is Associated with Symptomatic Presentation, Higher Parathyroid Hormone Levels, and Increased Gland Weight in Primary Hyperparathyroidism.
     J Clin Endocrinol Metab. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     July 2010
104. DURANTE C , Attard M, Torlontano M, Ronga G, et al
     Identification and Optimal Postsurgical Follow-Up of Patients with Very Low-Risk Papillary Thyroid Microcarcinomas.
     J Clin Endocrinol Metab. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     June 2010
105. TROCH M , Koperek O, Scheuba C, Dieckmann K, et al
     High Efficacy of Concomitant Treatment of Undifferentiated (Anaplastic) Thyroid Cancer with Radiation and Docetaxel.
     J Clin Endocrinol Metab. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
106. FAGGIANO A , Milone F, Ramundo V, Chiofalo MG, et al
     A Decrease of Calcitonin Serum Concentrations Less Than 50 Percent 30 Minutes after Thyroid Surgery Suggests Incomplete C-Cell Tumor Tissue Removal.
     J Clin Endocrinol Metab. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
107. PAES JE , Hua K, Nagy R, Kloos RT, et al
     The Relationship between Body Mass Index and Thyroid Cancer Pathology Features and Outcomes: A Clinicopathological Cohort Study.
     J Clin Endocrinol Metab. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: